OncoRix's breast cancer integrative solution demonstrated enhanced efficacy when combined with chemotherapy in an ex-vivo model

The ex-vivo model is based on a unique technology developed at the Weizmann Institute, and it can predict oncological treatment success and personalize the right treatment for each patient